Publication | Closed Access

Modified Donor Lymphocyte Infusion (DLI) for the Prophylaxis of Leukemia Relapse after Hematopoietic Stem Cell Transplantation in Patients with Advanced Leukemia—Feasibility and Safety Study

Hematological MalignancyCell TherapyTransplantationMarrow TransplantationAdvanced Leukemia—feasibilityStem Cell TransplantationHematologyImmunologyLeukemia RelapseImmunotherapyMedicineCell TransplantationDonor Lymphocyte Infusion